
|Articles|July 27, 2021
Pharmacy Clinical Pearl of the Day: Iron Deficiency, Anemia in Heart Failure Patients
Author(s)Saro Arakelians, PharmD
Heart failure outcomes improve with optimal iron levels.
Advertisement
Clinical Pearl of the Day:
- Patients with heart failure patients must be evaluated and treated for Iron deficiency and anemia.
- Prevalence over 50% in ambulatory patients.
- Iron deficiency in heart failure is defined as: ferritin < 100 µg/L or ferritin of 100-299 µg/L with a transferrin saturation <20%.
Explanation:
Iron deficiency:
- Should be screened and treated for patients with heart failure.
- Heart failure outcomes improve as iron levels improve.
- Intravenous iron replacement is needed because oral iron replacement trials do not show benefits.
- Risk factors for iron deficiency include female sex, advanced heart failure, higher levels of NTpro BNP and C reactive protein.
Reference
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
FDA Grants Orphan Drug Status to Immunotherapy for Acute Myeloid Leukemia Treatment
4
Gedatolisib Triplet Shows Significant PFS Benefit in HR+/HER2– Breast Cancer
5












































































































































































































